Modern Strategy for Preclinical Pharmaceutical R&D
Summary
The feel-good place to buy books
Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla
The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities.David Cavalla is an expert on secondary uses for existing drugs, or drug repurposing. He currrently operates through his consultancy, Numedicus Ltd, having worked in drug repurposing for 15 years. Previously he was CEO of Arachnova, and prior to that held various senior positions in pharmaceutical drug discovery at GSK and Napp Research Centre. He has written widely on drug discovery strategy, and is the author of 70 published papers and patents.
| SKU | Unavailable |
| ISBN 13 | 9780471971177 |
| ISBN 10 | 0471971170 |
| Title | Modern Strategy for Preclinical Pharmaceutical R&D |
| Author | David Cavalla |
| Condition | Unavailable |
| Binding Type | Hardback |
| Publisher | John Wiley & Sons Inc |
| Year published | 1997-03-21 |
| Number of pages | 228 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |